Tsutsumi et al., Supplemental Figure 1

Sep 13, 2014

10 likes | 66 Vues

80. 40. 80. 60. 0. 40. 10 0. 10 1. 10 2. 10 3. 20. Negative control. GA-FITC. GA-FITC + DMAG-N-oxide. 0. 10 0. 10 1. 10 2. 10 3. Negative control. mock. DMAG-N-oxide. Tsutsumi et al., Supplemental Figure 1. a. Cell Number (%). Fluorescence Intensity (log). b.

Share Presentation

Embed Code

Link

dmag
ga fitc
negative control
cell number
ga fitc dmag
fluorescence intensity log

paytah

Télécharger la présentation

Tsutsumi et al., Supplemental Figure 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

80 40 80 60 0 40 100 101 102 103 20 Negative control GA-FITC GA-FITC + DMAG-N-oxide 0 100 101 102 103 Negative control mock DMAG-N-oxide Tsutsumi et al., Supplemental Figure 1 a. Cell Number (%) Fluorescence Intensity (log) b. Cell Number (%) Fluorescence Intensity (log)

Lim et al, Supplemental Figure S1.

Lim et al, Supplemental Figure S1. . a/b. a. a. b/c. a/b. c/d. c/d. c/d. d. e. Arsenic. Plant height (Cm). f. g. [mg/Kg]. 1.5. 5.0. 7.0. 0. 10. 50. 100. 150. 0. 200. 300. 400. 500. 0. As[ μ M]. Cadmium. a/b. a. b. b. c. c. d. d. d/e. e. f. g.

154 views • 5 slides

Patel et al Supplemental Figure S4

A . Patel et al Supplemental Figure S4. 4.1 ± 1.9. SK-ES-1. 13.0 ± 3.8. SK- N-MC. 0. 4. 12. RASSF1A Fold Induction with 5-AZA treatment. B . 39.5 ± 14.5. SK-ES-1. 185.5 ± 45.6. SK- N-MC. 24.3 ± 5.9. A673. 0. 100. 150. 200. 50. CALCA Fold Induction with 5-AZA treatment.

94 views • 1 slides

Supplemental Figure 3. Kiem et al.

1500. 600. 300. 200. 100. 1500. 600. 300. 200. 100. Supplemental Figure 3. Kiem et al. a. Copy Number in Foamy Transduced Lymphocytes. 3. 2. Copy Number. 1. 0. FV-SMPGW. FV-UsI-SMPGW. FV-HsI-SMPGW. FV-SC46-IMPGW. FV-UsI-SC46-IMPGW. FV-UsIIUsIUR5-SMPGW. FV-HsIIHsIHR5-SMPGW.

73 views • 1 slides

Zang, et al. Supplemental Figure 2

Zang, et al. Supplemental Figure 2. Non-diabetic Diabetic Diabetic+S17834.

96 views • 1 slides

Yoon et al. Supplemental Figure S1

Yoon et al. Supplemental Figure S1. A. B. AGS. MKN-45. N87. CFPAC-1. PANC-1. AGS. MKN-45. N87. CFPAC-1. PANC-1. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Spheroid. Spheroid. Spheroid. Spheroid.

106 views • 1 slides

Supplemental Figure Fung et al.

Supplemental Figure Fung et al. A. B. Fluorescence and phase-contrast microscopic images showing ( A ) co-culture of MS5-GFP cells with human primary macrophages (including those encircled red). Note stellate network of MS5 cells (white arrows) spanning across an

133 views • 1 slides

Lim et al, Supplemental Figure S1.

Lim et al, Supplemental Figure S1. OsRING-H2 type : 4 OsRING-HC type : 6 OsRING-v type : 2. OsRING-H2 type : 5 OsRING-HC type : 1 OsRING-v type : 1. OsRING-H2 type : 9 OsRING-HC type : 8 OsRING-v type : 2. OsRING-H2 type : 9 OsRING-HC type : 8 OsRING-v type : 2.

205 views • 14 slides

Yoon et al. Supplemental Figure S3

Yoon et al. Supplemental Figure S3. A. AGS MKN-45 N87. Vismodegib. B. 5-fluoruracil. DMSO. Vismodegib. 5-fluoruracil. Cisplatin. Cisplatin. AGS Spheroid. MKN-45 Spheroid. N87 Spheroid.

120 views • 1 slides

Weaver et al. supplemental Figure 1

Weaver et al. supplemental Figure 1. A BALB/c. Epitope. Immunogen. Peptide. B1. B2. B3. B4. B5. B6. B7. B8. B9. B10. B11. B12. UG37(A). KVTFEPIPIHYCAPA (53). STVQCTHGIRPVVST (62). RIKQIINMWQRVGQA (104). GIVQQQSNLLRAIEAQQHLLKLTVWGIKQLQ (136,137,138,140).

103 views • 3 slides

Geng et al. Supplemental Figure 1

Geng et al. Supplemental Figure 1. murine 3B11 tumor vascular endothelial cells. Human micro-vascular endothelial cells. Analog II. DMSO. Geng et al Supplemental Figure 2. Geng et al Supplemental Figure 3. Geng et al Supplemental Figure 4. Geng et al Supplemental Figure 5.

199 views • 6 slides

Bush, et al., Supplemental Figure S3.

Bush, et al., Supplemental Figure S3. B. A. C. WT 1. WT1 -- Normal Karyotype. DAPI. KO2 Endoreduplication. Mean = 1.4%. p value = 0.001. KO1 -- 39, XX, -4, chtb(1), chtb(11), chtb(12). KO 2. DAPI. Mean = 4.4%. E. D.

88 views • 1 slides

Supplemental Figure 1 Narainsamy et al.

Supplemental Figure 1 Narainsamy et al. A. B. Supplemental Figure 2 Narainsamy et al. A. B. 3276. 1375. 757. 1438. Supplemental Figure 3 Narainsamy et al. B. Positive ion mode. Negative ion mode. <10. 10-25. 25-35. 35-50. >50. <10. 10-25. 25-35. 35-50. >50. CV (%).

145 views • 7 slides

Kraenzlin et al. Supplemental Figure 1

µV. 2.0e+5. PYD. 1.5e+5. ISTD. Fluorescence (295/400 nm). 1.0e+5. DPD. 0.5e+4. 0.0. -0.5e+4. 2. 4. 6. 8. 10. 12. Time (min). Kraenzlin et al. Supplemental Figure 1. Supplemental Figure 1:

81 views • 1 slides

Supplemental Figure 1 Purandare et al.

Supplemental Figure 1 Purandare et al. A. B. JAK2. 0 Percent Control Cut-Off. 33 Percent Control Cut-Off.

66 views • 1 slides

JH Neltner et al, Supplemental Figure 1

JH Neltner et al, Supplemental Figure 1. Gray matter (green boxes). White matter (yellow boxes). JH Neltner et al, Supplemental Figure 2. A. B. CD 31 CD 34 Collagen IV SMA Factor VIII. C. D. E. F. G. H. I. J.

126 views • 2 slides

Vernin et al., supplemental Figure 5

PI positive cells (%). Vernin et al., supplemental Figure 5.

92 views • 1 slides

Supplemental Figure 1, Ghielmetti et al

Supplemental Figure 1, Ghielmetti et al.

84 views • 1 slides

Supplemental Figure 3, Ghielmetti et al

medium. TB40/E. TB40/E-UV. Supplemental Figure 3, Ghielmetti et al.

94 views • 1 slides

Supplemental Figure 1 Geffroy et al.

CNL-B19. CNL-BA8. l B35. CNL-BA11. l B29. CNL-J11. l J9. Supplemental Figure 1 Geffroy et al. BAT93. JaloEEP558. Genetic position 1. Genetic position 1. 10Kb. CNL-J8. l J39. CNL-JA78. l J107. CNL-J9. l J15. Genetic position 2. CNL-B16. CNL-B17. l B10. Genetic position 3.

98 views • 1 slides

Kiem et al., Supplemental Figure 1

Kiem et al., Supplemental Figure 1. Relative luciferase expression. control. human CCR5-741. human CCR5-1024. macaque CCR5-741. macaque CCR5-1024.

87 views • 1 slides

Glazov et al., Supplemental Figure 6

Glazov et al., Supplemental Figure 6.

115 views • 1 slides

Frietze et al. Supplemental Figure 1

Frietze et al. Supplemental Figure 1.

60 views • 1 slides

More Related